RayzeBio planning $150M in radiopharmaceutical facilities in Whitestown
The company, which is owned by biopharmaceutical giant Bristol Myers Squibb Co., is working on an incentive package with Whitestown officials that includes tax abatements for construction and new equipment for two buildings.